{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T07:01:20Z","timestamp":1772953280375,"version":"3.50.1"},"reference-count":25,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2002,11,18]],"date-time":"2002-11-18T00:00:00Z","timestamp":1037577600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2002,12]]},"abstract":"<jats:p><jats:bold>Summary.<\/jats:bold> Soluble <jats:sc>l<\/jats:sc>\u2010selectin (sCD62L) plasma concentrations at diagnosis and outcome were investigated in 193 children at first relapse of acute lymphoblastic leukaemia (ALL) after treatment according to the Berlin\u2013Frankfurt\u2013M\u00fcnster relapsed ALL multicentre trials, ALL\u2010REZ BFM 95 and 96. sCD62L was low (&lt; fifth paediatric reference percentile) in 63 (33%) and high (&gt; 95th percentile) in 36 (19%) children, and was independent of remission duration, sex, BCR\u2013ABL fusion or extramedullary disease. High sCD62L was associated with circulating blasts and T\u2010cell phenotype. More initial adverse events occurred in children with high and low levels of sCD62L (23 out of 99) than in those with normal levels (9 out of 94, <jats:italic>P<\/jats:italic> = 0\u00b7018). Among 75 worst\u2010prognosis patients (risk groups S3\/S4, isolated bone marrow relapse occurring less than 6 months after elective cessation of front\u2010line therapy, or T\u2010cell phenotype with bone marrow involvement), 27 had low sCD62L and decreased event\u2010free survival (EFS) probability (P<jats:sub>EFS5<\/jats:sub> = 0\u00b709 at 5 years) and duration (219 d) compared with normal sCD62L (29 out of 75, P<jats:sub>EFS5<\/jats:sub> = 0\u00b724, 640 d, <jats:italic>P<\/jats:italic> = 0\u00b701). Low (44 out of 118), normal (72 out of 118), and high (19 out of 118) sCD62L non\u2010S3\/S4 patients fared similarly (average P<jats:sub>EFS5<\/jats:sub> = 0\u00b745, 1369 d; <jats:italic>P<\/jats:italic> = 0\u00b75). Low sCD62L may be a marker of malignant blasts replacing normal sCD62L\u2010producing haematopoietic cells. In children with first relapse of ALL and worst prognosis, plasma sCD62L may be useful for risk\u2010adapted stratification.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2002.03897.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:48:58Z","timestamp":1047365338000},"page":"677-684","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Soluble <scp>l<\/scp>\u2010selectin (sCD62L) in relapsed childhood acute lymphoblastic leukaemia"],"prefix":"10.1111","volume":"119","author":[{"given":"Ralf","family":"Herold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietger","family":"Stibenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcnter","family":"Henze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"B\u00fchrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,11,18]]},"reference":[{"key":"e_1_2_11_2_1","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukemias","volume":"9","author":"Bene M.C.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(98)00156-8"},{"key":"e_1_2_11_4_1","first-page":"442","article-title":"Lymphocyte activation and expression of the human leucocyte\u2010endothelial cell adhesion molecule 1 (Leu\u20108\/TQ1 antigen)","volume":"71","author":"B\u00fchrer C.","year":"1990","journal-title":"Immunology"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199509000-00011"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.10.2812"},{"key":"e_1_2_11_7_1","volume-title":"Analysis of Survival Data. Monographs on Statistics and Applied Probability.","author":"Cox D.","year":"1984"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199809092695"},{"key":"e_1_2_11_9_1","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1182\/blood.V92.9.3115","article-title":"Relationship between cleaved l\u2010selectin levels and the outcome of acute myeloid leukemia","volume":"92","author":"Extermann M.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780090710"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2551036"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.2000.13.1.85"},{"key":"e_1_2_11_13_1","first-page":"71","volume-title":"Survival Analysis","author":"Miller R.","year":"1981"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00510.x"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-200x.1999.01062.x"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.2307\/2344317"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.119.1.229"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/69.1.239"},{"key":"e_1_2_11_19_1","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1182\/blood.V91.5.1716.1716_1716_1722","article-title":"TEL\u2010AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia","volume":"91","author":"Seeger K.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.1.191"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/349691a0"},{"key":"e_1_2_11_22_1","first-page":"300","article-title":"Regulation of leukocyte adhesion molecule\u20101 (TQ1, Leu\u20108) expression and shedding by normal and malignant cells","volume":"5","author":"Spertini O.","year":"1991","journal-title":"Leukemia"},{"key":"e_1_2_11_23_1","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1182\/blood.V84.4.1249.1249","article-title":"High levels of the shed form of l\u2010selectin are present in patients with acute leukemia and inhibit blast cell adhesion to activated endothelium","volume":"84","author":"Spertini O.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90276-7"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.8.3109.3109"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1993.tb01603.x"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03897.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03897.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2002.03897.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T14:28:45Z","timestamp":1697380125000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2002.03897.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11,18]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["10.1046\/j.1365-2141.2002.03897.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2002.03897.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11,18]]},"assertion":[{"value":"2002-11-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}